341205 Sigma-AldrichEtoposide - CAS 33419-42-0 - Calbiochem
Etoposide, CAS 33419-42-0, is cell-permeable inhibitor of topoisomerase II inhibitor (IC50 = 59.2 µM). Displays anti-tumor activity.
More>> Etoposide, CAS 33419-42-0, is cell-permeable inhibitor of topoisomerase II inhibitor (IC50 = 59.2 µM). Displays anti-tumor activity. Less<<Synonyms: VP-16
Recommended Products
개요
| Replacement Information |
|---|
주요 사양표
| CAS # | Empirical Formula |
|---|---|
| 33419-42-0 | C₂₉H₃₂O₁₃ |
가격 및 재고여부
| 카탈로그 번호 | 재고 정보 | 패킹 | 포장 단위 | 가격(VAT 별도) | 수량 | |
|---|---|---|---|---|---|---|
| 341205-25MGCN |
|
Plastic ampoule | 25 mg |
|
— |
| Product Information | |
|---|---|
| CAS number | 33419-42-0 |
| ATP Competitive | N |
| Form | White solid |
| Hill Formula | C₂₉H₃₂O₁₃ |
| Chemical formula | C₂₉H₃₂O₁₃ |
| Reversible | N |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications | |
|---|---|
| Application | Etoposide, CAS 33419-42-0, is cell-permeable inhibitor of topoisomerase II inhibitor (IC50 = 59.2 µM). Displays anti-tumor activity. |
| Biological Information | |
|---|---|
| Primary Target | topoisomerase 2 |
| Primary Target IC<sub>50</sub> | 59.2 µM inhibiting topoisomerase II |
| Purity | >95% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS | |
|---|---|
| RTECS | KC0190000 |
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| 카탈로그 번호 | GTIN |
| 341205-25MGCN | 04055977215434 |
Documentation
Etoposide - CAS 33419-42-0 - Calbiochem MSDS
| 타이틀 |
|---|
Etoposide - CAS 33419-42-0 - Calbiochem Certificates of Analysis
| Title | Lot Number |
|---|---|
| 341205 |
References
| 참고문헌 보기 |
|---|
| De Lange, A.M., et al. 1995. J. Virol. 69, 2082. Kaufman, S.H., et al. 1993. Cancer Res. 53, 3976. Onishi, Y., et al. 1993. Biochim. Biophys. Acta 1175, 147. Terada, T., et al. 1993. J. Med. Chem. 36, 1689. Wazniak, A.J., et al. 1991. J. Clin. Oncol. 9, 70. Einhorn, L.H., et al. 1988. J. Clin. Oncol. 6, 451. Issel, B.F. 1982. Cancer Chemother. Pharmacol. 7, 73. |



